OP was speaking less about software and more about tech startup culture. Theranos comes to mind. Shoddy MVPs work well for consumer software but are dangerous in the medical field where the results could be life or death. The question is how can existing processes help/hurt a transition to medical field or will it require a radically different approach that doesn't gain from existing expertise (or at least without thorough consideration).

There are just as many companies in Silicon Valley that do biotech right. Theranos didn’t struggle because of “Silicon Valley Culture,” it struggles because of fraud and outright lies.

I wish you the best of luck in doing this well. The profession of nursing is live-critical important, and incredibly demanding.